U.S. market Closed. Opens in 2 hours 2 minutes

GMED | Globus Medical, Inc. Stock Overview

(Stock Exchange: NYSE)
Day's Range 82.35 - 83.91
52 Week Range 44.02 - 84.87
Beta 1.15
Implied Volatility 20.04%
IV Rank 14.52%
Day's Volume 904,406
Average Volume 763,292
Shares Outstanding 136,167,343
Market Cap 11,382,228,201
Sector Healthcare
Industry Medical - Devices
IPO Date 2012-08-03
Valuation
Profitability
Growth
Health
P/E Ratio 134.82
Forward P/E Ratio N/A
EPS 0.62
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 5,000
Country USA
Website GMED
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
GMED's peers: ATEC, BIO, CNMD, OFIX, LIVN, ITGR, IRTC, HSKA, NUVA, GKOS, BRKR, NVRO, PODD, INSP, NVCR, NARI, HQY, PHG, SNN
*Chart delayed
Analyzing fundamentals for GMED we got that it has weak fundamentals where Valuation is considered to be overvalued, Profitability is unacceptably poor, Growth is good and Health is strong. For more detailed analysis please see GMED Fundamentals page.

Watching at GMED technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on GMED Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙